Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Enroll crawled date : 2021 - 04 - 29 save search
BD Announces Enrollment in Post-Market Studies of the WavelinQ™ Arteriovenous Endovascular Fistula
Published: 2021-04-29 (Crawled : 18:00) - biospace.com/
BDX | $233.83 -0.23% 0.0% 6
|
Health Technology
|
| O: 0.25%
H: 0.04%
C: -2.61%
enroll
Aerie Pharmaceuticals Completes Enrollment of its Phase 2b Clinical Trial of AR-15512 (TRPM8 Agonist) Ophthalmic Solution for the Treatment of Patients with Dry Eye Disease
Published: 2021-04-29 (Crawled : 14:00) - biospace.com/
AERI | $15.25 0.0%
|
Health Technology
|
| O: -0.11%
H: 2.16%
C: -1.36%
dry eye disease treatment phase 2 eye eye disease phase 2b trial enroll
Can-Fite’s Phase III Psoriasis Study Achieves 75% Enrollment; Top Line Results Expected Q4 2021
Published: 2021-04-29 (Crawled : 13:15) - biospace.com/
CANF | $1.94 -1.52% 5.67% 5.7K
|
Health Technology
|
| O: 1.83%
H: 0.45%
C: -1.35%
results topline psoriasis enroll
Gainers vs Losers
| 61% | 39% |
Top 10 Gainers
BOF | $2.08 77.78% 39.06% 110M
|
BHIL | $0.1793 -4.37% 19.24% 340K
|
Agriculture, Forestry, Fishing ...
UMAC | $1.48 -1.33% 14.87% 20K
|
CI | $352.28 -0.11% 13.53% 2
|
Health Services
CIG.C | $2.89 -1.37% 12.8% 2.3K
|
n/a
MTH | $154.69 -2.21% 12.68% 450K
|
Consumer Durables
HCP | News | $31.41 7.75% 11.26% 1.2M
|
BMTX 4 | $1.545 0.98% 10.03% 2.5K
|
Information
TAL | $12.26 0.57% 9.22% 12M
|
Consumer Services
ASXC | $0.243 -2.41% 7.0% 1.1M
|
Manufacturing
Your saved searches
Save your searches and get alerts when important news are released.